Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Febuxostat Tablets

Approval Number

国药准字H20249847

Company湖北广济药业股份有限公司

Registration Date

December 25, 2024

Drug Information

Generic Name

非布司他片

Dosage Form

片剂

Strength

40mg

Drug Type

化学药品

Registration Date

December 25, 2024

Company Information

Applicant Company

Company Name湖北广济药业股份有限公司

Company Address

湖北省武穴市大金镇梅武路100号

Manufacturing Company

Company Name湖北广济药业股份有限公司

Company Address

湖北省黄冈武穴市大金广济药业生物产业园A区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

非布司他片 - NMPA 批准文号 | MedPath